Corcept Therapeutics (NASDAQ:CORT) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.06, Briefing.com reports. The business had revenue of $123.60 million during the quarter, compared to analyst estimates of $119.71 million. Corcept Therapeutics had […]